The Connecticut Research and Experimental Expenditures Tax Credit (RC Credit) and Research and Development Expenditures Tax Credit (RDC Credit), administered by the Connecticut Department of Revenue Services, incentivize qualified research activities conducted within the state. Enacted under Conn. Gen. Stat. §§ 12-217j and 12-217n, these credits offset corporation business tax liabilities. As of November 28, 2025, enhancements under H.B. 7287 (Public Act 25-168, signed June 30, 2025) boost refund exchanges for qualifying small biotechnology companies.
Eligibility requires conducting qualified research activities (QRAs) in Connecticut that meet IRC § 41 standards, including technological uncertainty elimination through experimentation. Businesses must file as C corporation taxpayers under Chapter 208 (Corporation Business Tax). S corporations currently cannot claim due to no entity-level tax liability and lack of flow-through provisions.
Connecticut offers two distinct credits: the incremental RC Credit (20% on excess over base) and the non-incremental RDC Credit (flat or tiered rates). The same research dollars cannot be used in full for both RC and RDC in the same year. In practice, taxpayers typically run both calculations and use whichever formula gives the better result for a given year’s QREs. All calculations use Connecticut-sourced QREs only, aligned with IRC §§ 41 and 174. No Alternative Simplified Credit (ASC) option is available.
Connecticut's R&D credits feature targeted provisions for small businesses, biotech, and refunds to support innovation in pharmaceuticals, manufacturing, and tech sectors.
Real results from a Connecticut biotech startup recovering credits to fuel expansion.
Connecticut's RC Credit provides 20% on incremental QREs over the prior year, while the RDC Credit offers 6% for small businesses (<$100M gross income) or tiered rates up to 6% for larger firms, per Conn. Gen. Stat. §§ 12-217j and 12-217n.
Activities must satisfy IRC § 41's four-part test: technological in nature, aimed at business component improvement, eliminating uncertainty, and involving experimentation. Examples include developing new software or improving manufacturing processes in Connecticut. Strike Tax verifies qualifying projects.
For $2M in QREs above the prior-year base, a business could save about $400,000 through the RC Credit (20% of the excess), before considering any federal benefit. In practice, you generally choose between the RC and RDC formulas for a given set of QREs in a year, rather than applying both to the same expenses. Use Strike Tax’s R&D Credit Calculator for personalized estimates.
Nonrefundable by default, but QSBs (<$70M gross income) can exchange unused credits for 65% cash refunds (90% for biotech in 2025), capped at $1.5M annually. Strike Tax maximizes refund elections.
File Form CT-1120RC with your corporation business tax return, including detailed documentation. For refunds, use Form CT-1120XCH. No pre-approval needed, but comply with federal IRC § 41. Strike Tax handles filing and substantiation.
Yes, stack state RC/RDC with federal IRC § 41 credits on the same Connecticut QREs for amplified savings. Strike Tax optimizes dual claims.
Pharma, biotech, and manufacturing see the highest returns due to high QREs and biotech refund bonuses (biotechnology companies meeting the statutory definition). Strike Tax customizes for your sector.
H.B. 7287 enhances refund exchanges to 90% for qualifying small biotechnology companies (<$70M gross income), effective for income years beginning January 1, 2025. Broader pass-through eligibility (H.B. 7008) was proposed for 2026 but not enacted as of November 28, 2025.
Tiered: 1% up to $50M QREs, scaling to $5.5M + 6% over $200M, capped at 70% of liability. Valuable for sustained R&D in tech hubs.
Strike Tax ensures compliant claims, maximizes refunds and carryforwards, and provides audit-ready documentation tailored to Connecticut's rules.
Connect with us to find out how R&D tax credits can boost your organization’s bottom line.
Connecticut provides research and development (R&D) credits for C-Corporations. Connecticut refers to the two R&D tax credits as the Research and Experimental (Incremental) Expenditures Credit (RC Credit) and the Research and Development (Non-incremental) Expenditures Credit (RDC Credit). There are two credits available for Connecticut (RC and RDC).
The RC Credit is equal to 20% of the amount spent by the corporation directly on research and experimental expenditures over the amount spent on such expenditures incurring in the previous tax year. A Qualified Small Business (QSB) that cannot take this tax credit in an income year in which it could otherwise be taken, as a result of having no tax liability, may exchange the credits for a refundable amount equal to 65% of the value of the tax credit (see Form CT-1120 XCH).
Application MUST be made prior to the due date or extended due date of the return. The following information must accompany the filing of Form CT-1120RC:
The RDC Credit is also based on the amount of qualified R&D expenditures in Connecticut, and may be refundable for certain QSBs. For a QSB, the credit equals 6% of its qualified R&D expenditures. For all other companies, the RDC Credit is calculated as either:
Both the RC Credit and RDC Credit follows the definitions of IRC § 41 and IRC § 174, but have unique qualification criteria to consider.
Specifically, the following R&D expenses may qualify:
The following are examples of IRC §174 expenses that do not qualify:
Learn more about Connecticut's R&D Tax Credits or at an official Connecticut tax website.
R&D Tax Credit Available:
Yes
Eligible Entities:
C-Corporations only
Deadline for Tax Filing:
Due with Connecticut Tax Return
Data Required to Compute Credit:
Claim period Qualified R&D Expenses (QREs)
What Information is needed?
Qualified Research Expenses for Prior 1 Year
Credit Carryforward:
RC: 15 Years
RDC: Indefinitely
To get an estimate of the potential value of your unclaimed R&D Tax Credits, try out our credit calculator.

Download our R&D Tax Credit Calculator for Android to see how much you can receive from your qualified R&D tax credit expenses.
Connecticut's RC Credit provides 20% on incremental QREs over the prior year, while the RDC Credit offers 6% for small businesses (<$100M gross income) or tiered rates up to 6% for larger firms, per Conn. Gen. Stat. §§ 12-217j and 12-217n.
Activities must satisfy IRC § 41's four-part test: technological in nature, aimed at business component improvement, eliminating uncertainty, and involving experimentation. Examples include developing new software or improving manufacturing processes in Connecticut. Strike Tax verifies qualifying projects.
For $2M in QREs above the prior-year base, a business could save about $400,000 through the RC Credit (20% of the excess), before considering any federal benefit. In practice, you generally choose between the RC and RDC formulas for a given set of QREs in a year, rather than applying both to the same expenses. Use Strike Tax’s R&D Credit Calculator for personalized estimates.
Nonrefundable by default, but QSBs (<$70M gross income) can exchange unused credits for 65% cash refunds (90% for biotech in 2025), capped at $1.5M annually. Strike Tax maximizes refund elections.
File Form CT-1120RC with your corporation business tax return, including detailed documentation. For refunds, use Form CT-1120XCH. No pre-approval needed, but comply with federal IRC § 41. Strike Tax handles filing and substantiation.
Yes, stack state RC/RDC with federal IRC § 41 credits on the same Connecticut QREs for amplified savings. Strike Tax optimizes dual claims.
Pharma, biotech, and manufacturing see the highest returns due to high QREs and biotech refund bonuses (biotechnology companies meeting the statutory definition). Strike Tax customizes for your sector.
H.B. 7287 enhances refund exchanges to 90% for qualifying small biotechnology companies (<$70M gross income), effective for income years beginning January 1, 2025. Broader pass-through eligibility (H.B. 7008) was proposed for 2026 but not enacted as of November 28, 2025.
Tiered: 1% up to $50M QREs, scaling to $5.5M + 6% over $200M, capped at 70% of liability. Valuable for sustained R&D in tech hubs.
Strike Tax ensures compliant claims, maximizes refunds and carryforwards, and provides audit-ready documentation tailored to Connecticut's rules.